These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 2696739

  • 1. Glucocorticoid dexamethasone reversibly complements EJ-RAS oncogene to transform mouse embryo BALB-3T3 cells.
    Kovary K, Armelin MC, Armelin HA.
    J Cell Biochem; 1989 Dec; 41(4):171-7. PubMed ID: 2696739
    [Abstract] [Full Text] [Related]

  • 2. Ha-Ras-1 oncogene dosage differentially affects Balb/3T3 cells' growth factor requirement and tumorigenicity.
    Kovary K, Armelin MC, Armelin HA.
    Oncogene Res; 1989 Dec; 4(1):55-64. PubMed ID: 2654813
    [Abstract] [Full Text] [Related]

  • 3. [A study on reversion of the human activated c-Ha-ras-transformed cells].
    Ogiso Y.
    Hokkaido Igaku Zasshi; 1988 Sep; 63(5):687-97. PubMed ID: 3071518
    [Abstract] [Full Text] [Related]

  • 4. [Identification of a specific protein in flat revertant cell lines derived from ras oncogene-transformed cells].
    Fujita H.
    Hokkaido Igaku Zasshi; 1990 Mar; 65(2):210-20. PubMed ID: 2194920
    [Abstract] [Full Text] [Related]

  • 5. alpha6beta1-Integrin, a major cell surface carrier of beta1-6-branched oligosaccharides, mediates migration of EJ-ras-transformed fibroblasts on laminin-1 independently of its glycosylation state.
    Jasiulionis MG, Chammas R, Ventura AM, Travassos LR, Brentani RR.
    Cancer Res; 1996 Apr 01; 56(7):1682-9. PubMed ID: 8603420
    [Abstract] [Full Text] [Related]

  • 6. Expression and phenotypic alterations caused by an inducible transforming ras oncogene introduced into rat liver epithelial cells.
    Huber BE, Cordingley MG.
    Oncogene; 1988 Sep 01; 3(3):245-56. PubMed ID: 3060790
    [Abstract] [Full Text] [Related]

  • 7. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
    Gray GD, Hernandez OM, Hebel D, Root M, Pow-Sang JM, Wickstrom E.
    Cancer Res; 1993 Feb 01; 53(3):577-80. PubMed ID: 8425190
    [Abstract] [Full Text] [Related]

  • 8. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
    Storer RD, Stein RB, Sina JF, DeLuca JG, Allen HL, Bradley MO.
    Cancer Res; 1986 Mar 01; 46(3):1458-64. PubMed ID: 3510726
    [Abstract] [Full Text] [Related]

  • 9. Regulation of bradykinin B2 receptors by the ras oncogene: evidence for multiple mechanisms.
    Hembree TN, Leeb-Lundberg LM.
    J Cell Physiol; 1996 Nov 01; 169(2):248-55. PubMed ID: 8908192
    [Abstract] [Full Text] [Related]

  • 10. Human retinoblastoma gene product prevents c-Ha-ras oncogene mediated cellular transformation of mouse fibroblasts.
    Kivinen L, Pitkänen K, Laiho M.
    Oncogene; 1993 Oct 01; 8(10):2703-11. PubMed ID: 8378082
    [Abstract] [Full Text] [Related]

  • 11. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
    Okimoto T, Kohno K, Kuwano M, Gopas J, Kung HF, Ono M.
    Oncogene; 1996 Apr 18; 12(8):1625-33. PubMed ID: 8622882
    [Abstract] [Full Text] [Related]

  • 12. Loss of glucocorticoid-dependent growth inhibition in transformed mouse lung cells.
    Li J, Johnson TA, Hanson LA, Beer DG.
    Mol Carcinog; 1996 Aug 18; 16(4):213-20. PubMed ID: 8784464
    [Abstract] [Full Text] [Related]

  • 13. CD44 protein levels and its biological activity are regulated in Balb/c 3T3 fibroblasts by serum factors and by transformation with the ras but not with the sis oncogene.
    Kogerman P, Sy MS, Culp LA.
    J Cell Physiol; 1996 Nov 18; 169(2):341-9. PubMed ID: 8908201
    [Abstract] [Full Text] [Related]

  • 14. Altered extracellular matrices influence cellular processes and nuclear matrix organizations of overlying human bladder urothelial cells.
    Gordon JN, Shu WP, Schlussel RN, Droller MJ, Liu BC.
    Cancer Res; 1993 Oct 15; 53(20):4971-7. PubMed ID: 8402687
    [Abstract] [Full Text] [Related]

  • 15. EJ-ras oncogene transfection of endothelial cells upregulates the expression of syndecan-4 and downregulates heparan sulfate sulfotransferases and epimerase.
    Lopes CC, Toma L, Pinhal MA, Porcionatto MA, Sogayar MC, Dietrich CP, Nader HB.
    Biochimie; 2006 Oct 15; 88(10):1493-504. PubMed ID: 16793191
    [Abstract] [Full Text] [Related]

  • 16. Loss of growth factor dependence and conversion of transforming growth factor-beta 1 inhibition to stimulation in metastatic H-ras-transformed murine fibroblasts.
    Schwarz LC, Gingras MC, Goldberg G, Greenberg AH, Wright JA.
    Cancer Res; 1988 Dec 15; 48(24 Pt 1):6999-7003. PubMed ID: 3056609
    [Abstract] [Full Text] [Related]

  • 17. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
    Coppa A, Mincione G, Lazzereschi D, Ranieri A, Turco A, Lucignano B, Scarpa S, Ragano-Caracciolo M, Colletta G.
    J Cell Physiol; 1997 Aug 15; 172(2):200-8. PubMed ID: 9258341
    [Abstract] [Full Text] [Related]

  • 18. [Involvement of cAMP dependent protein kinase in the reversion of a NIH/3T3 cell line transformed by a ras oncogene (EJ-NIH/3T3)].
    Oda A.
    Hokkaido Igaku Zasshi; 1988 Sep 15; 63(5):747-53. PubMed ID: 3071519
    [Abstract] [Full Text] [Related]

  • 19. p21ras-mediated decrease of the retinoblastoma protein in fibroblasts occurs through growth factor-dependent mechanisms.
    Kivinen L, Tiihonen E, Haapajärvi T, Laiho M.
    Cell Growth Differ; 1996 Dec 15; 7(12):1705-12. PubMed ID: 8959339
    [Abstract] [Full Text] [Related]

  • 20. Epidermal growth factor and the control of proliferation of Balb 3T3 and benzo[a]pyrene-transformed Balb 3T3 cells.
    Brown KD, Holley RW.
    J Cell Physiol; 1979 Jul 15; 100(1):139-46. PubMed ID: 313933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.